FDA Warns Degasa Over Water System, Insufficient Microbial Testing

Drug Industry Daily
A A
Drug manufacturer Degasa did not adequately test its products or include all necessary data in laboratory records, according to a warning letter from the FDA.

To View This Article:

Login

Subscribe To Drug Industry Daily